Back to 
Lido Advisors, LLC
Lido Advisors, LLC
CMMB1 quarters
Position history for Lido Advisors, LLC's holdings in CHEMOMAB THERAPEUTICS LTD
Yes. Lido Advisors holds 14,341 shares of CMMB (Chemomab Therapeutics), worth $23,232, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$23,232
Current Shares
14,341
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of CMMB: MORGAN STANLEY, CITADEL ADVISORS LLC, JANE STREET GROUP, LLC